Ravi Viswanathan, 10% Owner at AVEO PHARMACEUTICALS INC (AVEO), bought 250,600 shares at $2.00 ($491K) on 2018-07-19, disclosed to the SEC on 2018-07-20.
Open-market purchase of $491k AVEO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.95 | 200,000 | $390K | 79.4% |
| 2 | $2.00 | 50,600 | $101K | 20.6% |
| Total | $1.96 avg | 250,600 | $491K | 100% |
| Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |
| AVEO | BUY | 2018-05-21 | $897K | — | Filing → |